nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—breast cancer—colon cancer	0.666	1	CtDrD
Toremifene—ABCB1—colon cancer	0.214	1	CbGaD
Toremifene—CYP1A2—Fluorouracil—colon cancer	0.0139	0.237	CbGbCtD
Toremifene—ABCB1—Irinotecan—colon cancer	0.0127	0.216	CbGbCtD
Toremifene—ABCB1—Vincristine—colon cancer	0.0111	0.189	CbGbCtD
Toremifene—CYP3A4—Irinotecan—colon cancer	0.00759	0.13	CbGbCtD
Toremifene—ABCB1—Methotrexate—colon cancer	0.00671	0.114	CbGbCtD
Toremifene—CYP3A4—Vincristine—colon cancer	0.00664	0.113	CbGbCtD
Toremifene—Thromboembolic event—Irinotecan—colon cancer	0.0019	0.0385	CcSEcCtD
Toremifene—Paresis—Vincristine—colon cancer	0.00144	0.0292	CcSEcCtD
Toremifene—Thromboembolic event—Capecitabine—colon cancer	0.00127	0.0258	CcSEcCtD
Toremifene—Thromboembolic event—Methotrexate—colon cancer	0.000948	0.0192	CcSEcCtD
Toremifene—Embolism—Irinotecan—colon cancer	0.000798	0.0162	CcSEcCtD
Toremifene—Thrombosis—Irinotecan—colon cancer	0.000724	0.0147	CcSEcCtD
Toremifene—Disorder sight—Capecitabine—colon cancer	0.00072	0.0146	CcSEcCtD
Toremifene—Paresis—Methotrexate—colon cancer	0.000699	0.0142	CcSEcCtD
Toremifene—Deep vein thrombosis—Capecitabine—colon cancer	0.000563	0.0114	CcSEcCtD
Toremifene—Embolism—Capecitabine—colon cancer	0.000534	0.0108	CcSEcCtD
Toremifene—Appetite absent—Methotrexate—colon cancer	0.000513	0.0104	CcSEcCtD
Toremifene—Pulmonary embolism—Irinotecan—colon cancer	0.000512	0.0104	CcSEcCtD
Toremifene—Hypercalcaemia—Capecitabine—colon cancer	0.000493	0.01	CcSEcCtD
Toremifene—Thrombosis—Capecitabine—colon cancer	0.000484	0.00981	CcSEcCtD
Toremifene—ESR1—blood vessel—colon cancer	0.000471	0.107	CbGeAlD
Toremifene—Vaginal haemorrhage—Capecitabine—colon cancer	0.000463	0.00938	CcSEcCtD
Toremifene—Thrombophlebitis—Irinotecan—colon cancer	0.00043	0.0087	CcSEcCtD
Toremifene—Rigors—Capecitabine—colon cancer	0.00042	0.00851	CcSEcCtD
Toremifene—Deep vein thrombosis—Methotrexate—colon cancer	0.000419	0.0085	CcSEcCtD
Toremifene—Polyp—Methotrexate—colon cancer	0.000419	0.0085	CcSEcCtD
Toremifene—Vaginal discharge—Methotrexate—colon cancer	0.000419	0.0085	CcSEcCtD
Toremifene—Thrombophlebitis—Fluorouracil—colon cancer	0.000411	0.00833	CcSEcCtD
Toremifene—Embolism—Methotrexate—colon cancer	0.000398	0.00805	CcSEcCtD
Toremifene—Musculoskeletal stiffness—Capecitabine—colon cancer	0.000382	0.00774	CcSEcCtD
Toremifene—Cyst—Methotrexate—colon cancer	0.000382	0.00774	CcSEcCtD
Toremifene—Skin discolouration—Capecitabine—colon cancer	0.00038	0.00769	CcSEcCtD
Toremifene—Liver disorder—Methotrexate—colon cancer	0.000374	0.00759	CcSEcCtD
Toremifene—Cardiac failure—Fluorouracil—colon cancer	0.000365	0.00739	CcSEcCtD
Toremifene—Lethargy—Fluorouracil—colon cancer	0.000363	0.00736	CcSEcCtD
Toremifene—Cataract—Capecitabine—colon cancer	0.00036	0.0073	CcSEcCtD
Toremifene—Ataxia—Vincristine—colon cancer	0.000359	0.00727	CcSEcCtD
Toremifene—Coordination abnormal—Capecitabine—colon cancer	0.000349	0.00707	CcSEcCtD
Toremifene—Pulmonary embolism—Capecitabine—colon cancer	0.000343	0.00695	CcSEcCtD
Toremifene—Ataxia—Fluorouracil—colon cancer	0.000335	0.00678	CcSEcCtD
Toremifene—Dry eye—Capecitabine—colon cancer	0.000317	0.00642	CcSEcCtD
Toremifene—Angina pectoris—Irinotecan—colon cancer	0.000313	0.00634	CcSEcCtD
Toremifene—Angina pectoris—Fluorouracil—colon cancer	0.0003	0.00607	CcSEcCtD
Toremifene—Abnormal vision—Capecitabine—colon cancer	0.000299	0.00606	CcSEcCtD
Toremifene—Acute coronary syndrome—Vincristine—colon cancer	0.00029	0.00588	CcSEcCtD
Toremifene—Neuropathy peripheral—Vincristine—colon cancer	0.000288	0.00584	CcSEcCtD
Toremifene—Myocardial infarction—Vincristine—colon cancer	0.000288	0.00584	CcSEcCtD
Toremifene—Thrombophlebitis—Capecitabine—colon cancer	0.000287	0.00582	CcSEcCtD
Toremifene—Musculoskeletal stiffness—Methotrexate—colon cancer	0.000284	0.00576	CcSEcCtD
Toremifene—Skin discolouration—Methotrexate—colon cancer	0.000283	0.00572	CcSEcCtD
Toremifene—Acute coronary syndrome—Irinotecan—colon cancer	0.000282	0.00572	CcSEcCtD
Toremifene—Sweating—Vincristine—colon cancer	0.000282	0.00571	CcSEcCtD
Toremifene—ESR1—embryo—colon cancer	0.000281	0.0635	CbGeAlD
Toremifene—Myocardial infarction—Irinotecan—colon cancer	0.000281	0.00569	CcSEcCtD
Toremifene—Jaundice—Irinotecan—colon cancer	0.000279	0.00566	CcSEcCtD
Toremifene—Sweating—Irinotecan—colon cancer	0.000275	0.00557	CcSEcCtD
Toremifene—Acute coronary syndrome—Fluorouracil—colon cancer	0.000271	0.00548	CcSEcCtD
Toremifene—Myocardial infarction—Fluorouracil—colon cancer	0.000269	0.00545	CcSEcCtD
Toremifene—Neuropathy peripheral—Fluorouracil—colon cancer	0.000269	0.00545	CcSEcCtD
Toremifene—Hot flush—Capecitabine—colon cancer	0.000266	0.00539	CcSEcCtD
Toremifene—Menopausal symptoms—Capecitabine—colon cancer	0.000264	0.00534	CcSEcCtD
Toremifene—Arthritis—Capecitabine—colon cancer	0.000256	0.00519	CcSEcCtD
Toremifene—Pulmonary embolism—Methotrexate—colon cancer	0.000255	0.00517	CcSEcCtD
Toremifene—Cardiac failure—Capecitabine—colon cancer	0.000255	0.00517	CcSEcCtD
Toremifene—Lethargy—Capecitabine—colon cancer	0.000254	0.00515	CcSEcCtD
Toremifene—Diplopia—Capecitabine—colon cancer	0.000249	0.00504	CcSEcCtD
Toremifene—Visual impairment—Irinotecan—colon cancer	0.000248	0.00502	CcSEcCtD
Toremifene—Angiopathy—Vincristine—colon cancer	0.00024	0.00486	CcSEcCtD
Toremifene—Mediastinal disorder—Vincristine—colon cancer	0.000238	0.00482	CcSEcCtD
Toremifene—Mood swings—Capecitabine—colon cancer	0.000236	0.00478	CcSEcCtD
Toremifene—Ataxia—Capecitabine—colon cancer	0.000234	0.00474	CcSEcCtD
Toremifene—Alopecia—Vincristine—colon cancer	0.000233	0.00473	CcSEcCtD
Toremifene—Angiopathy—Irinotecan—colon cancer	0.000233	0.00473	CcSEcCtD
Toremifene—Mediastinal disorder—Irinotecan—colon cancer	0.000232	0.0047	CcSEcCtD
Toremifene—Mental disorder—Vincristine—colon cancer	0.000231	0.00469	CcSEcCtD
Toremifene—Chills—Irinotecan—colon cancer	0.000231	0.00468	CcSEcCtD
Toremifene—Arrhythmia—Irinotecan—colon cancer	0.00023	0.00466	CcSEcCtD
Toremifene—Liver function test abnormal—Capecitabine—colon cancer	0.00023	0.00465	CcSEcCtD
Toremifene—ESR1—epithelium—colon cancer	0.000229	0.0518	CbGeAlD
Toremifene—Alopecia—Irinotecan—colon cancer	0.000227	0.00461	CcSEcCtD
Toremifene—Breast disorder—Capecitabine—colon cancer	0.000225	0.00456	CcSEcCtD
Toremifene—Back pain—Vincristine—colon cancer	0.000222	0.00451	CcSEcCtD
Toremifene—ESR1—smooth muscle tissue—colon cancer	0.000221	0.05	CbGeAlD
Toremifene—Arrhythmia—Fluorouracil—colon cancer	0.00022	0.00446	CcSEcCtD
Toremifene—Alopecia—Fluorouracil—colon cancer	0.000218	0.00441	CcSEcCtD
Toremifene—Back pain—Irinotecan—colon cancer	0.000217	0.00439	CcSEcCtD
Toremifene—Thrombophlebitis—Methotrexate—colon cancer	0.000214	0.00434	CcSEcCtD
Toremifene—ESR1—renal system—colon cancer	0.000213	0.0481	CbGeAlD
Toremifene—Angina pectoris—Capecitabine—colon cancer	0.00021	0.00424	CcSEcCtD
Toremifene—Vertigo—Vincristine—colon cancer	0.000207	0.00419	CcSEcCtD
Toremifene—Leukopenia—Vincristine—colon cancer	0.000206	0.00417	CcSEcCtD
Toremifene—Vision blurred—Fluorouracil—colon cancer	0.000202	0.00409	CcSEcCtD
Toremifene—Vertigo—Irinotecan—colon cancer	0.000201	0.00408	CcSEcCtD
Toremifene—Leukopenia—Irinotecan—colon cancer	0.0002	0.00406	CcSEcCtD
Toremifene—Weight increased—Capecitabine—colon cancer	0.000196	0.00397	CcSEcCtD
Toremifene—Leukopenia—Fluorouracil—colon cancer	0.000192	0.00389	CcSEcCtD
Toremifene—Acute coronary syndrome—Capecitabine—colon cancer	0.000189	0.00383	CcSEcCtD
Toremifene—Lethargy—Methotrexate—colon cancer	0.000189	0.00383	CcSEcCtD
Toremifene—Myocardial infarction—Capecitabine—colon cancer	0.000188	0.00381	CcSEcCtD
Toremifene—Neuropathy peripheral—Capecitabine—colon cancer	0.000188	0.00381	CcSEcCtD
Toremifene—Oedema—Vincristine—colon cancer	0.000188	0.0038	CcSEcCtD
Toremifene—Jaundice—Capecitabine—colon cancer	0.000187	0.00379	CcSEcCtD
Toremifene—ABCB1—blood vessel—colon cancer	0.000186	0.0421	CbGeAlD
Toremifene—Nervous system disorder—Vincristine—colon cancer	0.000184	0.00373	CcSEcCtD
Toremifene—Thrombocytopenia—Vincristine—colon cancer	0.000184	0.00372	CcSEcCtD
Toremifene—Oedema—Irinotecan—colon cancer	0.000183	0.0037	CcSEcCtD
Toremifene—Chest pain—Fluorouracil—colon cancer	0.000183	0.0037	CcSEcCtD
Toremifene—Hyperhidrosis—Vincristine—colon cancer	0.000181	0.00368	CcSEcCtD
Toremifene—Hepatobiliary disease—Capecitabine—colon cancer	0.000181	0.00367	CcSEcCtD
Toremifene—Nervous system disorder—Irinotecan—colon cancer	0.000179	0.00363	CcSEcCtD
Toremifene—Thrombocytopenia—Irinotecan—colon cancer	0.000179	0.00363	CcSEcCtD
Toremifene—Anorexia—Vincristine—colon cancer	0.000179	0.00362	CcSEcCtD
Toremifene—ESR1—lymphoid tissue—colon cancer	0.000177	0.0399	CbGeAlD
Toremifene—Hyperhidrosis—Irinotecan—colon cancer	0.000177	0.00358	CcSEcCtD
Toremifene—Mood swings—Methotrexate—colon cancer	0.000175	0.00356	CcSEcCtD
Toremifene—Oedema—Fluorouracil—colon cancer	0.000175	0.00355	CcSEcCtD
Toremifene—ESR1—digestive system—colon cancer	0.000175	0.0394	CbGeAlD
Toremifene—CYP1A1—epithelium—colon cancer	0.000174	0.0394	CbGeAlD
Toremifene—Anorexia—Irinotecan—colon cancer	0.000174	0.00353	CcSEcCtD
Toremifene—Ataxia—Methotrexate—colon cancer	0.000174	0.00353	CcSEcCtD
Toremifene—Nervous system disorder—Fluorouracil—colon cancer	0.000172	0.00348	CcSEcCtD
Toremifene—Thrombocytopenia—Fluorouracil—colon cancer	0.000171	0.00347	CcSEcCtD
Toremifene—Liver function test abnormal—Methotrexate—colon cancer	0.000171	0.00347	CcSEcCtD
Toremifene—Insomnia—Vincristine—colon cancer	0.00017	0.00344	CcSEcCtD
Toremifene—Breast disorder—Methotrexate—colon cancer	0.000167	0.00339	CcSEcCtD
Toremifene—Anorexia—Fluorouracil—colon cancer	0.000167	0.00338	CcSEcCtD
Toremifene—Visual impairment—Capecitabine—colon cancer	0.000166	0.00336	CcSEcCtD
Toremifene—Insomnia—Irinotecan—colon cancer	0.000165	0.00335	CcSEcCtD
Toremifene—CYP1A2—renal system—colon cancer	0.000164	0.0371	CbGeAlD
Toremifene—Decreased appetite—Vincristine—colon cancer	0.000163	0.0033	CcSEcCtD
Toremifene—Dyspnoea—Irinotecan—colon cancer	0.000163	0.0033	CcSEcCtD
Toremifene—Gastrointestinal disorder—Vincristine—colon cancer	0.000162	0.00328	CcSEcCtD
Toremifene—CYP1A1—renal system—colon cancer	0.000162	0.0366	CbGeAlD
Toremifene—Fatigue—Vincristine—colon cancer	0.000162	0.00328	CcSEcCtD
Toremifene—Eye disorder—Capecitabine—colon cancer	0.000161	0.00326	CcSEcCtD
Toremifene—Constipation—Vincristine—colon cancer	0.00016	0.00325	CcSEcCtD
Toremifene—Pain—Vincristine—colon cancer	0.00016	0.00325	CcSEcCtD
Toremifene—Decreased appetite—Irinotecan—colon cancer	0.000159	0.00322	CcSEcCtD
Toremifene—Insomnia—Fluorouracil—colon cancer	0.000158	0.00321	CcSEcCtD
Toremifene—Gastrointestinal disorder—Irinotecan—colon cancer	0.000158	0.0032	CcSEcCtD
Toremifene—Fatigue—Irinotecan—colon cancer	0.000158	0.00319	CcSEcCtD
Toremifene—Pain—Irinotecan—colon cancer	0.000156	0.00317	CcSEcCtD
Toremifene—Constipation—Irinotecan—colon cancer	0.000156	0.00317	CcSEcCtD
Toremifene—Angiopathy—Capecitabine—colon cancer	0.000156	0.00316	CcSEcCtD
Toremifene—Dyspnoea—Fluorouracil—colon cancer	0.000156	0.00316	CcSEcCtD
Toremifene—Mediastinal disorder—Capecitabine—colon cancer	0.000155	0.00314	CcSEcCtD
Toremifene—Chills—Capecitabine—colon cancer	0.000154	0.00313	CcSEcCtD
Toremifene—ESR1—vagina—colon cancer	0.000154	0.0348	CbGeAlD
Toremifene—Arrhythmia—Capecitabine—colon cancer	0.000154	0.00312	CcSEcCtD
Toremifene—Decreased appetite—Fluorouracil—colon cancer	0.000152	0.00308	CcSEcCtD
Toremifene—Alopecia—Capecitabine—colon cancer	0.000152	0.00308	CcSEcCtD
Toremifene—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000151	0.00306	CcSEcCtD
Toremifene—Mental disorder—Capecitabine—colon cancer	0.000151	0.00306	CcSEcCtD
Toremifene—Malnutrition—Capecitabine—colon cancer	0.00015	0.00304	CcSEcCtD
Toremifene—Pain—Fluorouracil—colon cancer	0.00015	0.00303	CcSEcCtD
Toremifene—Back pain—Capecitabine—colon cancer	0.000145	0.00294	CcSEcCtD
Toremifene—Vision blurred—Capecitabine—colon cancer	0.000141	0.00286	CcSEcCtD
Toremifene—Tremor—Capecitabine—colon cancer	0.00014	0.00284	CcSEcCtD
Toremifene—Sweating—Methotrexate—colon cancer	0.000137	0.00277	CcSEcCtD
Toremifene—Hepatobiliary disease—Methotrexate—colon cancer	0.000135	0.00274	CcSEcCtD
Toremifene—Vertigo—Capecitabine—colon cancer	0.000135	0.00273	CcSEcCtD
Toremifene—Asthenia—Vincristine—colon cancer	0.000135	0.00273	CcSEcCtD
Toremifene—CYP1A2—digestive system—colon cancer	0.000135	0.0304	CbGeAlD
Toremifene—Leukopenia—Capecitabine—colon cancer	0.000134	0.00272	CcSEcCtD
Toremifene—CYP1A1—digestive system—colon cancer	0.000133	0.03	CbGeAlD
Toremifene—Asthenia—Irinotecan—colon cancer	0.000131	0.00266	CcSEcCtD
Toremifene—ESR1—liver—colon cancer	0.00013	0.0294	CbGeAlD
Toremifene—Chest pain—Capecitabine—colon cancer	0.000128	0.00259	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000127	0.00257	CcSEcCtD
Toremifene—Dizziness—Vincristine—colon cancer	0.000124	0.00251	CcSEcCtD
Toremifene—Pruritus—Fluorouracil—colon cancer	0.000124	0.00251	CcSEcCtD
Toremifene—Visual impairment—Methotrexate—colon cancer	0.000124	0.0025	CcSEcCtD
Toremifene—Oedema—Capecitabine—colon cancer	0.000122	0.00248	CcSEcCtD
Toremifene—Dizziness—Irinotecan—colon cancer	0.000121	0.00245	CcSEcCtD
Toremifene—Nervous system disorder—Capecitabine—colon cancer	0.00012	0.00243	CcSEcCtD
Toremifene—Eye disorder—Methotrexate—colon cancer	0.00012	0.00243	CcSEcCtD
Toremifene—Thrombocytopenia—Capecitabine—colon cancer	0.00012	0.00243	CcSEcCtD
Toremifene—Vomiting—Vincristine—colon cancer	0.000119	0.00242	CcSEcCtD
Toremifene—Skin disorder—Capecitabine—colon cancer	0.000119	0.00241	CcSEcCtD
Toremifene—CYP3A4—renal system—colon cancer	0.000119	0.0268	CbGeAlD
Toremifene—Rash—Vincristine—colon cancer	0.000118	0.0024	CcSEcCtD
Toremifene—Hyperhidrosis—Capecitabine—colon cancer	0.000118	0.0024	CcSEcCtD
Toremifene—Dermatitis—Vincristine—colon cancer	0.000118	0.00239	CcSEcCtD
Toremifene—Headache—Vincristine—colon cancer	0.000118	0.00238	CcSEcCtD
Toremifene—CYP1A1—vagina—colon cancer	0.000117	0.0265	CbGeAlD
Toremifene—Anorexia—Capecitabine—colon cancer	0.000117	0.00236	CcSEcCtD
Toremifene—Angiopathy—Methotrexate—colon cancer	0.000116	0.00236	CcSEcCtD
Toremifene—Vomiting—Irinotecan—colon cancer	0.000116	0.00235	CcSEcCtD
Toremifene—Dizziness—Fluorouracil—colon cancer	0.000116	0.00235	CcSEcCtD
Toremifene—Mediastinal disorder—Methotrexate—colon cancer	0.000115	0.00234	CcSEcCtD
Toremifene—Rash—Irinotecan—colon cancer	0.000115	0.00233	CcSEcCtD
Toremifene—Dermatitis—Irinotecan—colon cancer	0.000115	0.00233	CcSEcCtD
Toremifene—Chills—Methotrexate—colon cancer	0.000115	0.00233	CcSEcCtD
Toremifene—Headache—Irinotecan—colon cancer	0.000114	0.00232	CcSEcCtD
Toremifene—Alopecia—Methotrexate—colon cancer	0.000113	0.00229	CcSEcCtD
Toremifene—Mental disorder—Methotrexate—colon cancer	0.000112	0.00227	CcSEcCtD
Toremifene—Malnutrition—Methotrexate—colon cancer	0.000112	0.00226	CcSEcCtD
Toremifene—Nausea—Vincristine—colon cancer	0.000111	0.00226	CcSEcCtD
Toremifene—Vomiting—Fluorouracil—colon cancer	0.000111	0.00225	CcSEcCtD
Toremifene—ABCB1—embryo—colon cancer	0.000111	0.0251	CbGeAlD
Toremifene—Insomnia—Capecitabine—colon cancer	0.000111	0.00224	CcSEcCtD
Toremifene—Rash—Fluorouracil—colon cancer	0.00011	0.00224	CcSEcCtD
Toremifene—Dermatitis—Fluorouracil—colon cancer	0.00011	0.00223	CcSEcCtD
Toremifene—Headache—Fluorouracil—colon cancer	0.00011	0.00222	CcSEcCtD
Toremifene—Dyspnoea—Capecitabine—colon cancer	0.000109	0.00221	CcSEcCtD
Toremifene—Nausea—Irinotecan—colon cancer	0.000109	0.0022	CcSEcCtD
Toremifene—Back pain—Methotrexate—colon cancer	0.000108	0.00219	CcSEcCtD
Toremifene—Decreased appetite—Capecitabine—colon cancer	0.000106	0.00215	CcSEcCtD
Toremifene—Gastrointestinal disorder—Capecitabine—colon cancer	0.000106	0.00214	CcSEcCtD
Toremifene—Fatigue—Capecitabine—colon cancer	0.000105	0.00214	CcSEcCtD
Toremifene—Vision blurred—Methotrexate—colon cancer	0.000105	0.00213	CcSEcCtD
Toremifene—Pain—Capecitabine—colon cancer	0.000105	0.00212	CcSEcCtD
Toremifene—Constipation—Capecitabine—colon cancer	0.000105	0.00212	CcSEcCtD
Toremifene—Nausea—Fluorouracil—colon cancer	0.000104	0.00211	CcSEcCtD
Toremifene—CYP1A2—liver—colon cancer	0.0001	0.0227	CbGeAlD
Toremifene—Vertigo—Methotrexate—colon cancer	0.0001	0.00203	CcSEcCtD
Toremifene—Leukopenia—Methotrexate—colon cancer	9.99e-05	0.00202	CcSEcCtD
Toremifene—ESR1—lymph node—colon cancer	9.97e-05	0.0225	CbGeAlD
Toremifene—CYP1A1—liver—colon cancer	9.89e-05	0.0223	CbGeAlD
Toremifene—CYP3A4—digestive system—colon cancer	9.74e-05	0.022	CbGeAlD
Toremifene—Chest pain—Methotrexate—colon cancer	9.5e-05	0.00192	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	9.43e-05	0.00191	CcSEcCtD
Toremifene—ABCB1—epithelium—colon cancer	9.06e-05	0.0205	CbGeAlD
Toremifene—Nervous system disorder—Methotrexate—colon cancer	8.93e-05	0.00181	CcSEcCtD
Toremifene—Thrombocytopenia—Methotrexate—colon cancer	8.91e-05	0.00181	CcSEcCtD
Toremifene—Skin disorder—Methotrexate—colon cancer	8.84e-05	0.00179	CcSEcCtD
Toremifene—Hyperhidrosis—Methotrexate—colon cancer	8.8e-05	0.00178	CcSEcCtD
Toremifene—Asthenia—Capecitabine—colon cancer	8.78e-05	0.00178	CcSEcCtD
Toremifene—Anorexia—Methotrexate—colon cancer	8.68e-05	0.00176	CcSEcCtD
Toremifene—Pruritus—Capecitabine—colon cancer	8.65e-05	0.00175	CcSEcCtD
Toremifene—ABCB1—renal system—colon cancer	8.41e-05	0.019	CbGeAlD
Toremifene—Insomnia—Methotrexate—colon cancer	8.23e-05	0.00167	CcSEcCtD
Toremifene—Dyspnoea—Methotrexate—colon cancer	8.12e-05	0.00164	CcSEcCtD
Toremifene—Dizziness—Capecitabine—colon cancer	8.09e-05	0.00164	CcSEcCtD
Toremifene—Decreased appetite—Methotrexate—colon cancer	7.91e-05	0.0016	CcSEcCtD
Toremifene—Gastrointestinal disorder—Methotrexate—colon cancer	7.86e-05	0.00159	CcSEcCtD
Toremifene—Fatigue—Methotrexate—colon cancer	7.85e-05	0.00159	CcSEcCtD
Toremifene—Pain—Methotrexate—colon cancer	7.79e-05	0.00158	CcSEcCtD
Toremifene—Vomiting—Capecitabine—colon cancer	7.78e-05	0.00158	CcSEcCtD
Toremifene—Rash—Capecitabine—colon cancer	7.71e-05	0.00156	CcSEcCtD
Toremifene—Dermatitis—Capecitabine—colon cancer	7.7e-05	0.00156	CcSEcCtD
Toremifene—Headache—Capecitabine—colon cancer	7.66e-05	0.00155	CcSEcCtD
Toremifene—CYP1A1—lymph node—colon cancer	7.58e-05	0.0171	CbGeAlD
Toremifene—ESR1—ATF-2 transcription factor network—BCL2L1—colon cancer	7.49e-05	0.00925	CbGpPWpGaD
Toremifene—Nausea—Capecitabine—colon cancer	7.26e-05	0.00147	CcSEcCtD
Toremifene—CYP3A4—liver—colon cancer	7.26e-05	0.0164	CbGeAlD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MSH2—colon cancer	7.18e-05	0.00887	CbGpPWpGaD
Toremifene—ESR1—Nuclear Receptor transcription pathway—PPARG—colon cancer	7.13e-05	0.0088	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—BAX—colon cancer	7.12e-05	0.00879	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	7.07e-05	0.00873	CbGpPWpGaD
Toremifene—ABCB1—lymphoid tissue—colon cancer	6.98e-05	0.0158	CbGeAlD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	6.97e-05	0.00861	CbGpPWpGaD
Toremifene—ABCB1—digestive system—colon cancer	6.89e-05	0.0156	CbGeAlD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	6.78e-05	0.00838	CbGpPWpGaD
Toremifene—CYP3A4—Irinotecan Pathway—APC—colon cancer	6.77e-05	0.00836	CbGpPWpGaD
Toremifene—Asthenia—Methotrexate—colon cancer	6.53e-05	0.00132	CcSEcCtD
Toremifene—ESR1—Estrogen signaling pathway—PIK3CA—colon cancer	6.52e-05	0.00806	CbGpPWpGaD
Toremifene—Pruritus—Methotrexate—colon cancer	6.44e-05	0.00131	CcSEcCtD
Toremifene—ABCB1—bone marrow—colon cancer	6.36e-05	0.0144	CbGeAlD
Toremifene—ESR1—Leptin signaling pathway—BCL2L1—colon cancer	6.18e-05	0.00763	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	6.11e-05	0.00754	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	6.09e-05	0.00752	CbGpPWpGaD
Toremifene—ABCB1—vagina—colon cancer	6.09e-05	0.0138	CbGeAlD
Toremifene—Dizziness—Methotrexate—colon cancer	6.02e-05	0.00122	CcSEcCtD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	5.98e-05	0.00739	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—CCND1—colon cancer	5.92e-05	0.00731	CbGpPWpGaD
Toremifene—Vomiting—Methotrexate—colon cancer	5.79e-05	0.00117	CcSEcCtD
Toremifene—Rash—Methotrexate—colon cancer	5.74e-05	0.00116	CcSEcCtD
Toremifene—Dermatitis—Methotrexate—colon cancer	5.74e-05	0.00116	CcSEcCtD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	5.71e-05	0.00705	CbGpPWpGaD
Toremifene—Headache—Methotrexate—colon cancer	5.7e-05	0.00116	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—EP300—colon cancer	5.45e-05	0.00673	CbGpPWpGaD
Toremifene—Nausea—Methotrexate—colon cancer	5.41e-05	0.0011	CcSEcCtD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—SRC—colon cancer	5.4e-05	0.00667	CbGpPWpGaD
Toremifene—ESR1—Estrogen signaling pathway—AKT1—colon cancer	5.33e-05	0.00658	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	5.32e-05	0.00657	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	5.26e-05	0.00649	CbGpPWpGaD
Toremifene—ESR1—FOXA1 transcription factor network—EP300—colon cancer	5.25e-05	0.00648	CbGpPWpGaD
Toremifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.22e-05	0.00644	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—NRAS—colon cancer	5.19e-05	0.00642	CbGpPWpGaD
Toremifene—ABCB1—liver—colon cancer	5.14e-05	0.0116	CbGeAlD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—EP300—colon cancer	5.06e-05	0.00625	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—SRC—colon cancer	4.92e-05	0.00608	CbGpPWpGaD
Toremifene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	4.85e-05	0.00599	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	4.8e-05	0.00592	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—MYC—colon cancer	4.75e-05	0.00586	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	4.74e-05	0.00585	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	4.71e-05	0.00582	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—MYC—colon cancer	4.66e-05	0.00575	CbGpPWpGaD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	4.62e-05	0.0057	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.56e-05	0.00564	CbGpPWpGaD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	4.51e-05	0.00557	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—CCND1—colon cancer	4.51e-05	0.00557	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—KRAS—colon cancer	4.47e-05	0.00552	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	4.45e-05	0.00549	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—MYC—colon cancer	4.41e-05	0.00545	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	4.32e-05	0.00533	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—colon cancer	4.22e-05	0.00522	CbGpPWpGaD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.16e-05	0.00514	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—EP300—colon cancer	4.15e-05	0.00513	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—colon cancer	4.11e-05	0.00507	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	4.08e-05	0.00504	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—BAX—colon cancer	4.07e-05	0.00502	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	4.03e-05	0.00498	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—CCND1—colon cancer	4.02e-05	0.00497	CbGpPWpGaD
Toremifene—ABCB1—lymph node—colon cancer	3.94e-05	0.0089	CbGeAlD
Toremifene—ESR1—AP-1 transcription factor network—CCND1—colon cancer	3.93e-05	0.00486	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—CTNNB1—colon cancer	3.89e-05	0.00481	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—EP300—colon cancer	3.89e-05	0.0048	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—TP53—colon cancer	3.82e-05	0.00472	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—HRAS—colon cancer	3.8e-05	0.00469	CbGpPWpGaD
Toremifene—CYP1A1—Arachidonic acid metabolism—PTGS2—colon cancer	3.77e-05	0.00466	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—CCND1—colon cancer	3.72e-05	0.0046	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—EP300—colon cancer	3.62e-05	0.00447	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	3.59e-05	0.00443	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	3.56e-05	0.0044	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	3.53e-05	0.00435	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.5e-05	0.00432	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	3.47e-05	0.00428	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	3.39e-05	0.00419	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	3.38e-05	0.00418	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.37e-05	0.00416	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—FGFR3—colon cancer	3.36e-05	0.00415	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—AKT1—colon cancer	3.36e-05	0.00414	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	3.35e-05	0.00414	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—EP300—colon cancer	3.35e-05	0.00414	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—SRC—colon cancer	3.33e-05	0.00411	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	3.26e-05	0.00403	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—SRC—colon cancer	3.26e-05	0.00403	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—MYC—colon cancer	3.23e-05	0.00399	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	3.22e-05	0.00398	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—TGFB1—colon cancer	3.22e-05	0.00398	CbGpPWpGaD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	3.21e-05	0.00397	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	3.18e-05	0.00392	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—EGFR—colon cancer	3.16e-05	0.0039	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—MYC—colon cancer	3.15e-05	0.0039	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TGFB1—colon cancer	3.15e-05	0.00389	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	3.14e-05	0.00388	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	3.02e-05	0.00373	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—MYC—colon cancer	2.92e-05	0.00361	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	2.92e-05	0.0036	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—BRAF—colon cancer	2.91e-05	0.0036	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	2.86e-05	0.00353	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	2.86e-05	0.00353	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CDH1—colon cancer	2.85e-05	0.00352	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—HNF4A—colon cancer	2.84e-05	0.0035	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	2.81e-05	0.00347	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CA7—colon cancer	2.74e-05	0.00339	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	2.7e-05	0.00334	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TP53—colon cancer	2.59e-05	0.0032	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	2.57e-05	0.00318	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.57e-05	0.00317	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—PPARG—colon cancer	2.55e-05	0.00315	CbGpPWpGaD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	2.5e-05	0.00309	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	2.41e-05	0.00298	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	2.41e-05	0.00297	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—HRAS—colon cancer	2.34e-05	0.0029	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	2.3e-05	0.00284	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	2.25e-05	0.00278	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—AKT1—colon cancer	2.24e-05	0.00276	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DLC1—colon cancer	2.23e-05	0.00275	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.22e-05	0.00274	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CA7—colon cancer	2.19e-05	0.0027	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CASP3—colon cancer	2.18e-05	0.0027	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	2.14e-05	0.00264	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	2.14e-05	0.00264	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CCND1—colon cancer	2.13e-05	0.00263	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	2.11e-05	0.0026	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LGR5—colon cancer	2.1e-05	0.00259	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	2.08e-05	0.00257	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	2.08e-05	0.00257	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—AKT1—colon cancer	2.07e-05	0.00256	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CDKN1A—colon cancer	2.05e-05	0.00253	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	2.03e-05	0.0025	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	2.01e-05	0.00248	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	2e-05	0.00247	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—EP300—colon cancer	1.96e-05	0.00242	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.95e-05	0.00241	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	1.95e-05	0.0024	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CASP3—colon cancer	1.94e-05	0.0024	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.9e-05	0.00235	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	1.86e-05	0.0023	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	1.86e-05	0.0023	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	1.85e-05	0.00229	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.85e-05	0.00229	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	1.82e-05	0.00225	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	1.82e-05	0.00225	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—NRAS—colon cancer	1.82e-05	0.00225	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.81e-05	0.00224	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.78e-05	0.0022	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.76e-05	0.00218	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CA7—colon cancer	1.75e-05	0.00216	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.74e-05	0.00215	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	1.72e-05	0.00213	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	1.72e-05	0.00213	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MYC—colon cancer	1.71e-05	0.00211	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.7e-05	0.0021	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—EP300—colon cancer	1.67e-05	0.00206	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—EGFR—colon cancer	1.67e-05	0.00206	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CHST5—colon cancer	1.66e-05	0.00205	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ODC1—colon cancer	1.66e-05	0.00205	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—EGFR—colon cancer	1.66e-05	0.00205	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.65e-05	0.00203	CbGpPWpGaD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	1.63e-05	0.00202	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.62e-05	0.002	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.58e-05	0.00195	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—KRAS—colon cancer	1.58e-05	0.00195	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—KRAS—colon cancer	1.57e-05	0.00194	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.54e-05	0.0019	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.51e-05	0.00187	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AXIN2—colon cancer	1.51e-05	0.00186	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	1.46e-05	0.00181	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PIK3CA—colon cancer	1.44e-05	0.00178	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.41e-05	0.00175	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.41e-05	0.00174	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—colon cancer	1.4e-05	0.00173	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.38e-05	0.00171	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HNF4A—colon cancer	1.37e-05	0.00169	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.36e-05	0.00168	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CA7—colon cancer	1.35e-05	0.00167	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—HRAS—colon cancer	1.33e-05	0.00165	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ODC1—colon cancer	1.33e-05	0.00164	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CHST5—colon cancer	1.33e-05	0.00164	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.31e-05	0.00161	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—PPARG—colon cancer	1.23e-05	0.00152	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.21e-05	0.0015	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.2e-05	0.00148	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—AKT1—colon cancer	1.18e-05	0.00146	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—AKT1—colon cancer	1.18e-05	0.00145	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.16e-05	0.00143	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	1.13e-05	0.00139	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ODC1—colon cancer	1.06e-05	0.00131	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CHST5—colon cancer	1.06e-05	0.00131	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.03e-05	0.00127	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	9.8e-06	0.00121	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	9.57e-06	0.00118	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	9.32e-06	0.00115	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	9.23e-06	0.00114	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	9.02e-06	0.00111	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	8.58e-06	0.00106	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	8.34e-06	0.00103	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CHST5—colon cancer	8.17e-06	0.00101	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ODC1—colon cancer	8.17e-06	0.00101	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	8.12e-06	0.001	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	7.48e-06	0.000923	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	7.46e-06	0.000921	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	7.31e-06	0.000903	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—colon cancer	7.02e-06	0.000867	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	6.91e-06	0.000853	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.85e-06	0.000847	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	6.35e-06	0.000784	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	6.14e-06	0.000758	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARG—colon cancer	5.93e-06	0.000732	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.39e-06	0.000666	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.18e-06	0.00064	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.48e-06	0.000554	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCB1—colon cancer	4.39e-06	0.000542	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.37e-06	0.00054	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGFR3—colon cancer	4.35e-06	0.000537	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TYMS—colon cancer	4.31e-06	0.000532	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APC—colon cancer	3.99e-06	0.000493	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BRAF—colon cancer	3.75e-06	0.000464	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TYMS—colon cancer	3.44e-06	0.000425	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.44e-06	0.000425	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—colon cancer	3.38e-06	0.000417	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.32e-06	0.00041	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—colon cancer	3.05e-06	0.000377	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.86e-06	0.000353	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—colon cancer	2.81e-06	0.000348	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCB1—colon cancer	2.8e-06	0.000346	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TYMS—colon cancer	2.75e-06	0.000339	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—colon cancer	2.74e-06	0.000338	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CTNNB1—colon cancer	2.71e-06	0.000335	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1A—colon cancer	2.65e-06	0.000327	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EP300—colon cancer	2.52e-06	0.000311	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SRC—colon cancer	2.45e-06	0.000303	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—colon cancer	2.44e-06	0.000301	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—colon cancer	2.4e-06	0.000297	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—colon cancer	2.39e-06	0.000295	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NRAS—colon cancer	2.36e-06	0.000291	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—colon cancer	2.34e-06	0.000289	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—colon cancer	2.2e-06	0.000271	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—colon cancer	2.19e-06	0.000271	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCB1—colon cancer	2.16e-06	0.000267	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGFR—colon cancer	2.15e-06	0.000265	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TYMS—colon cancer	2.12e-06	0.000262	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.12e-06	0.000261	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KRAS—colon cancer	2.03e-06	0.000251	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—EP300—colon cancer	2e-06	0.000247	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—colon cancer	1.95e-06	0.00024	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—colon cancer	1.92e-06	0.000237	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—colon cancer	1.87e-06	0.00023	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—colon cancer	1.8e-06	0.000223	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HRAS—colon cancer	1.73e-06	0.000213	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—EP300—colon cancer	1.6e-06	0.000197	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—colon cancer	1.53e-06	0.000189	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—colon cancer	1.52e-06	0.000188	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—colon cancer	1.5e-06	0.000186	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—colon cancer	1.48e-06	0.000182	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—EP300—colon cancer	1.27e-06	0.000157	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—colon cancer	1.21e-06	0.000149	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—colon cancer	1.18e-06	0.000146	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—colon cancer	1.18e-06	0.000146	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—EP300—colon cancer	9.83e-07	0.000121	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—colon cancer	9.64e-07	0.000119	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—colon cancer	9.42e-07	0.000116	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—colon cancer	7.7e-07	9.51e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—colon cancer	7.27e-07	8.98e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—colon cancer	5.94e-07	7.34e-05	CbGpPWpGaD
